JP2021512954A5 - - Google Patents

Info

Publication number
JP2021512954A5
JP2021512954A5 JP2020564046A JP2020564046A JP2021512954A5 JP 2021512954 A5 JP2021512954 A5 JP 2021512954A5 JP 2020564046 A JP2020564046 A JP 2020564046A JP 2020564046 A JP2020564046 A JP 2020564046A JP 2021512954 A5 JP2021512954 A5 JP 2021512954A5
Authority
JP
Japan
Prior art keywords
methyl
trifluoromethyl
phenyl
quinazoline
pyrazine
Prior art date
Application number
JP2020564046A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021512954A (ja
JPWO2019156987A5 (https=
JP7382348B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/016705 external-priority patent/WO2019156987A1/en
Publication of JP2021512954A publication Critical patent/JP2021512954A/ja
Publication of JPWO2019156987A5 publication Critical patent/JPWO2019156987A5/ja
Publication of JP2021512954A5 publication Critical patent/JP2021512954A5/ja
Application granted granted Critical
Publication of JP7382348B2 publication Critical patent/JP7382348B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020564046A 2018-02-06 2019-02-05 AhRモジュレータ Active JP7382348B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201862626739P 2018-02-06 2018-02-06
US62/626,739 2018-02-06
US201962793260P 2019-01-16 2019-01-16
US62/793,260 2019-01-16
PCT/US2019/016705 WO2019156987A1 (en) 2018-02-06 2019-02-05 AhR MODULATORS

Publications (4)

Publication Number Publication Date
JP2021512954A JP2021512954A (ja) 2021-05-20
JPWO2019156987A5 JPWO2019156987A5 (https=) 2022-02-15
JP2021512954A5 true JP2021512954A5 (https=) 2022-02-15
JP7382348B2 JP7382348B2 (ja) 2023-11-16

Family

ID=65494575

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020564046A Active JP7382348B2 (ja) 2018-02-06 2019-02-05 AhRモジュレータ

Country Status (10)

Country Link
US (3) US10815250B2 (https=)
EP (2) EP4219495A1 (https=)
JP (1) JP7382348B2 (https=)
CN (1) CN111683950B (https=)
CA (1) CA3090150A1 (https=)
DK (1) DK3749669T6 (https=)
ES (1) ES2946632T7 (https=)
FI (1) FI3749669T6 (https=)
TW (1) TWI840343B (https=)
WO (1) WO2019156987A1 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019018562A1 (en) * 2017-07-19 2019-01-24 Ideaya Biosciences, Inc. AMIDO COMPOUND AS MODULATORS OF AHR
ES2946632T7 (es) 2018-02-06 2025-03-04 Ideaya Biosciences Inc Moduladores de AhR
EP4061484A1 (en) * 2019-11-22 2022-09-28 Senda Biosciences, Inc. Pyridopyrimidinone derivatives as ahr antagonists
WO2021210970A1 (en) * 2020-04-17 2021-10-21 Dong-A St Co., Ltd. Pyridopyrimidinone derivatives and their use as aryl hydrocarbon receptor modulators
WO2021236717A1 (en) 2020-05-20 2021-11-25 Senda Biosciences, Inc. Fused imidazole derivatives as ahr antagonists
CN114181212B (zh) * 2020-09-15 2023-06-06 山东轩竹医药科技有限公司 哒嗪酮类AhR抑制剂
CN116745622A (zh) * 2020-10-13 2023-09-12 先达生物科技公司 与免疫检查点抑制剂疗法相关的生物标志物及其使用方法
EP4228649A1 (en) * 2020-10-13 2023-08-23 Senda Biosciences, Inc. Biomarkers related to immune checkpoint inhibitor therapy and methods of using the same
WO2023020512A1 (zh) * 2021-08-16 2023-02-23 成都奥睿药业有限公司 取代的吡啶类似物、其制备方法及作为ahr调节剂的用途

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ515086A (en) 1999-04-28 2003-10-31 Aventis Pharma Gmbh Di-aryl acid derivatives as PPAR receptor ligands
JP2005504047A (ja) 2001-08-13 2005-02-10 チバ スペシャルティ ケミカルズ ホールディング インコーポレーテッド 紫外線吸収剤
US7098222B2 (en) 2004-05-12 2006-08-29 Abbott Laboratories Bicyclic-substituted amines having cyclic-substituted monocyclic substituents
US20050256118A1 (en) 2004-05-12 2005-11-17 Altenbach Robert J Bicyclic-substituted amines having cyclic-substituted monocyclic substituents
CR9465A (es) 2005-03-25 2008-06-19 Surface Logix Inc Compuestos mejorados farmacocineticamente
CA2617213C (en) 2005-07-29 2014-01-28 Resverlogix Corp. Pharmaceutical compositions for the prevention and treatment of complex diseases and their delivery by insertable medical devices
WO2008054599A2 (en) 2006-09-27 2008-05-08 Surface Logix, Inc. Rho kinase inhibitors
MX2010008376A (es) 2008-02-04 2011-02-22 Mercury Therapeutics Inc Moduladores ampk.
EA021938B1 (ru) 2008-05-01 2015-10-30 Сертрис Фармасьютикалз, Инк. Хинолины и их аналоги в качестве модуляторов сиртуина
CA2726164A1 (en) 2008-05-27 2009-12-23 The Board Of Regents Of The University Of Texas System Wnt protein signalling inhibitors
US20120202793A1 (en) 2009-03-09 2012-08-09 Paul Sweetnam Rho kinase inhibitors
US20120283282A1 (en) * 2009-06-18 2012-11-08 Arleen Rifkind Photoproducts of Tryptophan, Their Synthesis and Uses Thereof
BR112013002079B1 (pt) * 2010-07-27 2021-09-14 Trustees Of Boston University Modificadores do receptor de aril hidrocarboneto (ahr) como novos terapêuticos contra o câncer
CA2813711A1 (en) 2010-10-14 2012-04-19 Immunahr Ab 1,2-dihydro-4-hydroxy-2-oxo-quinoline-3-carboxanilides as ahr activators.
JP2013545749A (ja) 2010-11-10 2013-12-26 インフィニティー ファーマシューティカルズ, インコーポレイテッド 複素環化合物及びその使用
WO2012106343A2 (en) 2011-02-01 2012-08-09 The Board Of Trustees Of The University Of Illinois Hdac inhibitors and therapeutic methods using the same
CA2858069C (en) 2011-12-08 2020-02-11 Novartis Ag Compositions and methods for enhanced generation of hematopoietic stem/progenitor cells
CN111978319B (zh) 2014-06-27 2023-08-11 诺格拉制药有限公司 芳基受体调制剂及其制备和使用方法
US10669528B2 (en) 2015-06-25 2020-06-02 Children's Medical Center Corporation Methods and compositions relating to hematopoietic stem cell expansion, enrichment, and maintenance
WO2017184547A1 (en) 2016-04-18 2017-10-26 New York University Quinoline compounds as modulators of rage activity and uses thereof
TWI674260B (zh) 2017-02-01 2019-10-11 德商菲尼克斯製藥股份有限公司 芳基烴受體(AhR)調節劑化合物
TWI752155B (zh) 2017-02-01 2022-01-11 德商菲尼克斯製藥股份有限公司 芳香烴受體(AhR)調節劑化合物
TW201835070A (zh) 2017-02-21 2018-10-01 德商菲尼克斯製藥股份有限公司 芳香烴受體(AhR)調節劑化合物
WO2018195397A2 (en) 2017-04-21 2018-10-25 Kyn Therapeutics Indole ahr inhibitors and uses thereof
WO2019018562A1 (en) 2017-07-19 2019-01-24 Ideaya Biosciences, Inc. AMIDO COMPOUND AS MODULATORS OF AHR
ES2946632T7 (es) 2018-02-06 2025-03-04 Ideaya Biosciences Inc Moduladores de AhR
US20210254006A1 (en) 2018-06-06 2021-08-19 Ideaya Biosciences, Inc. Methods of culturing and/or expanding stem cells and/or lineage committed progenitor cells using lactam compounds

Similar Documents

Publication Publication Date Title
JP2021512954A5 (https=)
JP2016504363A5 (https=)
RU2015131148A (ru) СОЕДИНЕНИЯ, ГЕТЕРОБИЦИКЛО-ЗАМЕЩЕННЫЕ-[1, 2, 4]ТРИАЗОЛО[1, 5c]ХИНАЗОЛИН-5-АМИНА, ОБЛАДАЮЩИЕ СВОЙСТВАМИ А2А АНТАГОНИСТОВ
JP2021503004A5 (https=)
JP2021528467A5 (https=)
CN117651700A (zh) 2-氨基苯并噻唑化合物及使用方法
RU2012136907A (ru) Модуляторы гамма-секретазы
HRP20120105T1 (hr) Aminoheterociklički spojevi
JP2021519291A5 (https=)
JP2021528466A5 (https=)
JP2015511245A5 (https=)
RU2012152548A (ru) Пиридоновые и азапиридоновые соединения и способы применения
RU2018112230A (ru) Бициклические соединения в качестве ингибиторов atx
JPWO2020005873A5 (https=)
JP2021501806A5 (https=)
RU2016111675A (ru) Соединения биарилацетамида и способы их применения
JP2012515205A5 (https=)
JP2014506929A5 (https=)
JPWO2019191229A5 (https=)
FI3814357T3 (fi) Heterosykliset ja heteroaryliyhdisteet huntingtonin taudin hoitoon
JP2020522570A5 (https=)
JP2011500774A5 (https=)
JP2022502424A5 (https=)
JPWO2019191092A5 (https=)
KR920019794A (ko) 융합 헤테로시클릭 화합물, 그의 제조방법 및 용도